Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges Everest Group Q1 2026 Earnings Strong EPS Beat Highlights Underwriting Strength Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Over 40 Yet Stock Rises Strategic Education Inc STRA Q1 2026 Earnings EPS Misses Expectations as Revenue Details Remain Undisclosed Colony Bankcorp CBAN Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain HSLV Q1 2026 Earnings Stunning EPS Surprise of 1645 as Silver Production Exceeds Expectations